175 related articles for article (PubMed ID: 21529996)
1. Analgesic and nonsteroidal anti-inflammatory use in relation to nonmelanoma skin cancer: a population-based case-control study.
Torti DC; Christensen BC; Storm CA; Fortuny J; Perry AE; Zens MS; Stukel T; Spencer SK; Nelson HH; Karagas MR
J Am Acad Dermatol; 2011 Aug; 65(2):304-312. PubMed ID: 21529996
[TBL] [Abstract][Full Text] [Related]
2. Aspirin and nonsteroidal anti-inflammatory drug use and keratinocyte cancers: a large population-based cohort study of skin cancer in Australia.
Pandeya N; Olsen CM; Thompson BS; Dusingize JC; Neale RE; Green AC; Whiteman DC;
Br J Dermatol; 2019 Oct; 181(4):749-760. PubMed ID: 30920641
[TBL] [Abstract][Full Text] [Related]
3. Nonsteroidal anti-inflammatory drugs and the risk of nonmelanoma skin cancer.
Reinau D; Surber C; Jick SS; Meier CR
Int J Cancer; 2015 Jul; 137(1):144-53. PubMed ID: 25418602
[TBL] [Abstract][Full Text] [Related]
4. Nonsteroidal anti-inflammatory drugs and the risk of skin cancer: a population-based case-control study.
Johannesdottir SA; Chang ET; Mehnert F; Schmidt M; Olesen AB; Sørensen HT
Cancer; 2012 Oct; 118(19):4768-76. PubMed ID: 22644960
[TBL] [Abstract][Full Text] [Related]
5. Effect of non-steroidal anti-inflammatory drugs on non-melanoma skin cancer incidence in the SKICAP-AK trial.
Clouser MC; Roe DJ; Foote JA; Harris RB
Pharmacoepidemiol Drug Saf; 2009 Apr; 18(4):276-83. PubMed ID: 19226541
[TBL] [Abstract][Full Text] [Related]
6. Non-steroidal anti-inflammatory drugs, acetaminophen, and risk of skin cancer in the Nurses' Health Study.
Jeter JM; Han J; Martinez ME; Alberts DS; Qureshi AA; Feskanich D
Cancer Causes Control; 2012 Sep; 23(9):1451-61. PubMed ID: 22763500
[TBL] [Abstract][Full Text] [Related]
7. Effect of NSAIDs on the recurrence of nonmelanoma skin cancer.
Grau MV; Baron JA; Langholz B; Karagas M; Greenberg ER; Stukel TA; Mandel JS
Int J Cancer; 2006 Aug; 119(3):682-6. PubMed ID: 16496410
[TBL] [Abstract][Full Text] [Related]
8. Association between nonsteroidal anti-inflammatory drug use and cutaneous squamous cell carcinoma.
Asgari MM; Chren MM; Warton EM; Friedman GD; White E
Arch Dermatol; 2010 Apr; 146(4):388-95. PubMed ID: 20157019
[TBL] [Abstract][Full Text] [Related]
9. Nonsteroidal anti-inflammatory drugs and the risk of actinic keratoses and squamous cell cancers of the skin.
Butler GJ; Neale R; Green AC; Pandeya N; Whiteman DC
J Am Acad Dermatol; 2005 Dec; 53(6):966-72. PubMed ID: 16310056
[TBL] [Abstract][Full Text] [Related]
10. Associations of aspirin, nonsteroidal anti-inflammatory drug and paracetamol use with PSA-detected prostate cancer: findings from a large, population-based, case-control study (the ProtecT study).
Murad AS; Down L; Davey Smith G; Donovan JL; Athene Lane J; Hamdy FC; Neal DE; Martin RM
Int J Cancer; 2011 Mar; 128(6):1442-8. PubMed ID: 20506261
[TBL] [Abstract][Full Text] [Related]
11. Aspirin and nonsteroidal anti-inflammatory drugs can prevent cutaneous squamous cell carcinoma: a systematic review and meta-analysis.
Muranushi C; Olsen CM; Pandeya N; Green AC
J Invest Dermatol; 2015 Apr; 135(4):975-983. PubMed ID: 25521453
[TBL] [Abstract][Full Text] [Related]
12. Risk of basal cell carcinoma in a randomized clinical trial of aspirin and folic acid for the prevention of colorectal adenomas.
Passarelli MN; Barry EL; Zhang D; Gangar P; Rees JR; Bresalier RS; McKeown-Eyssen G; Karagas MR; Baron JA
Br J Dermatol; 2018 Aug; 179(2):337-344. PubMed ID: 29570772
[TBL] [Abstract][Full Text] [Related]
13. A randomized, 12-year primary-prevention trial of beta carotene supplementation for nonmelanoma skin cancer in the physician's health study.
Frieling UM; Schaumberg DA; Kupper TS; Muntwyler J; Hennekens CH
Arch Dermatol; 2000 Feb; 136(2):179-84. PubMed ID: 10677093
[TBL] [Abstract][Full Text] [Related]
14. Occurrence of other cancers among patients with prior basal cell and squamous cell skin cancer.
Karagas MR; Greenberg ER; Mott LA; Baron JA; Ernster VL
Cancer Epidemiol Biomarkers Prev; 1998 Feb; 7(2):157-61. PubMed ID: 9488591
[TBL] [Abstract][Full Text] [Related]
15. Declining incidence of keratinocyte carcinoma in organ transplant recipients.
Menzies S; O'Leary E; Callaghan G; Galligan M; Deady S; Gadallah B; Lenane P; Lally A; Houlihan DD; Morris PG; Sexton DJ; McCormick PA; Egan JJ; O'Neill JP; Conlon PJ; Moloney FJ
Br J Dermatol; 2019 Nov; 181(5):983-991. PubMed ID: 31049932
[TBL] [Abstract][Full Text] [Related]
16. Personal history of psoriasis and risk of nonmelanoma skin cancer (NMSC) among women in the United States: A population-based cohort study.
Dai H; Li WQ; Qureshi AA; Han J
J Am Acad Dermatol; 2016 Oct; 75(4):731-735. PubMed ID: 27436157
[TBL] [Abstract][Full Text] [Related]
17. Use of nonsteroidal anti-inflammatory drugs and risk of basal cell carcinoma in the United States Radiologic Technologists study.
Cahoon EK; Rajaraman P; Alexander BH; Doody MM; Linet MS; Freedman DM
Int J Cancer; 2012 Jun; 130(12):2939-48. PubMed ID: 21780102
[TBL] [Abstract][Full Text] [Related]
18. Association of ACE inhibitors and angiotensin receptor blockers with keratinocyte cancer prevention in the randomized VATTC trial.
Christian JB; Lapane KL; Hume AL; Eaton CB; Weinstock MA;
J Natl Cancer Inst; 2008 Sep; 100(17):1223-32. PubMed ID: 18728281
[TBL] [Abstract][Full Text] [Related]
19. Can oral nonsteroidal antiinflammatory drugs play a role in the prevention of basal cell carcinoma? A systematic review and metaanalysis.
Muranushi C; Olsen CM; Green AC; Pandeya N
J Am Acad Dermatol; 2016 Jan; 74(1):108-119.e1. PubMed ID: 26433247
[TBL] [Abstract][Full Text] [Related]
20. A large cohort study of nonsteroidal anti-inflammatory drug use and melanoma incidence.
Asgari MM; Maruti SS; White E
J Natl Cancer Inst; 2008 Jul; 100(13):967-71. PubMed ID: 18577752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
